Abstract: Computer program products, methods, systems, apparatus, and computing entities for tracking an item delivery are provided. In one embodiment, an item is associated with a vehicle (e.g., manned or unmanned terrestrial vehicle, nautical vehicle, and/or aerial vehicle) by updating item data in a database. An item tracking session is then generated based on the item data. Upon the determination that session availability trigger has occurred, access to the item tracking session is provided to a user. Data representing an updated location of the delivery vehicle is then used to update the item data to indicate the current location of the item as the updated location of the vehicle.

Abstract: Computer program products, methods, systems, apparatus, and computing entities for tracking an item delivery are provided. In one embodiment, an item is associated with a vehicle (e.g., manned or unmanned terrestrial vehicle, nautical vehicle, and/or aerial vehicle) by updating item data in a database. An item tracking session is then generated based on the item data. Upon the determination that session availability trigger has occurred, access to the item tracking session is provided to a user. Data representing an updated location of the delivery vehicle is then used to update the item data to indicate the current location of the item as the updated location of the vehicle.

Abstract: Computer program products, methods, systems, apparatus, and computing entities for tracking an item delivery are provided. In one embodiment, an item is associated with a vehicle (e.g., manned or unmanned terrestrial vehicle, nautical vehicle, and/or aerial vehicle) by updating item data in a database. An item tracking session is then generated based on the item data. Upon the determination that session availability trigger has occurred, access to the item tracking session is provided to a user. Data representing an updated location of the delivery vehicle is then used to update the item data to indicate the current location of the item as the updated location of the vehicle.

Abstract: Computer program products, methods, systems, apparatus, and computing entities for tracking an item delivery are provided. In one embodiment, an item is associated with a vehicle (e.g., manned or unmanned terrestrial vehicle, nautical vehicle, and/or aerial vehicle) by updating item data in a database. An item tracking session is then generated based on the item data. Upon the determination that session availability trigger has occurred, access to the item tracking session is provided to a user. Data representing an updated location of the delivery vehicle is then used to update the item data to indicate the current location of the item as the updated location of the vehicle.

Abstract: Computer program products, methods, systems, apparatus, and computing entities for tracking an item delivery are provided. In one embodiment, an item is associated with a vehicle (e.g., manned or unmanned terrestrial vehicle, nautical vehicle, and/or aerial vehicle) by updating item data in a database. An item tracking session is then generated based on the item data. Upon the determination that session availability trigger has occurred, access to the item tracking session is provided to a user. Data representing an updated location of the delivery vehicle is then used to update the item data to indicate the current location of the item as the updated location of the vehicle.

Abstract: Novel methods for making dosages form comprising a cushioning component. The methods of the present invention provides dosage forms which can be compressed to form compressed dosage forms that are substantially uniform in composition and robust and exhibit reduced friability. The invention also relates to methods for making fast-disintegrating dosage forms.

Abstract: A process for producing wet ribavirin pellets is provided in order to make pharmaceutical dosages of ribavirin. The process is particularly useful as an alternative method for preparing pharmaceutical dosages of ribavirin that reduces the amount of ribavirin dust that is produced during the manufacturing process and allows for greater control of dissolution rates. According to the preferred embodiments, this method is accomplished through mixing ribavirin with at least one excipient into a uniform mixture, forming the mixture into a granulated mass by adding a wetting agent, shaping said granulated mass into soluble particles and drying the flowable particles. The process enables Ribavirin pharmaceutical pellets to be mixed with a binder and disintegrant to form a uniform mixture.

Abstract: Ribavirin formulations are disclosed for use in capsules or tablets as well as processes for their preparation and methods for their administration.

Abstract: Novel methods for making dosages form comprising a cushioning component. The methods of the present invention provides dosage forms which can be compressed to form compressed dosage forms that are substantially uniform in composition and robust and exhibit reduced friability. The invention also relates to methods for making fast-disintegrating dosage forms.

Abstract: The current invention relies on a process already provided in great detail in U.S. Pat. No. 60/437,507 and an associated CIP filed on May 23, 2003 and hereby incorporated by reference. However, it was noted during additional studies that if the Cushioning Beads™ were milled to a particle size between about 10 mesh and about 50 mesh and to a most preferred size of 30-40 mesh, the Cushioning Beads™ did not loose their ability to protect coated particles during compression, as would be expected because of the fine milling. Moreover, it was also discovered that tablets compressed from the milled Cushioning Beads™ immediately disperse in the mouth. A final advantage of the current invention is the improved hardness and friability. The invention produces a tablet of 2Kp or 20N hardness. A vast improvement because it allows for use of conventional manufacturing and packaging equipment.

Abstract: The new process can be summarized in five general phases: the manufacture and coating of active-loaded beads with a sustained release coat, an enteric coat; a colonic coat, or a taste-masking coat; the manufacture of the cushioning components the co-processing of active-loaded beads with cushioning components into a single component known as a Cushioning Bead™; the use of freeze-drying to produce the intended outcome, and the compression of the resultant Cushioning Beads™ into tablets.

Abstract: A novel process for producing extended release formulation of a water-soluble drug comprising the steps of making a “modified drug” comprising a hot-melt granulation of the drug with soluble or dispersible polymeric material of a suitable molecular weight and melting point, coating portions of the modified drug to different thicknesses or weights so as to produce subbatches, and blending the subbatches to achieve a specific drug release profile.